Matinas BioPharma Holdings, Inc.

About Matinas Biopharma

Matinas BioPharma a clinical-stage biopharmaceutical company with a principal focus on identifying and developing novel and targeted pharmaceutical products for the treatment of various infectious diseases, with additional programs developing therapies to treat cardiovascular and metabolic conditions.

Learn about matinas biopharma Learn about Aquarius Biotechnologies

Drug Pipeline

MAT9001, Matinas BioPharma’s lead product candidate, is a next generation omega-3 prescription pharmaceutical product.

Learn about MAT9001

MAT8800 is Matinas BioPharma’s discovery program aiming to identify and optimize omega-3 compositions for the treatment of fatty liver diseases.

Learn about MAT8800

Stock Snapshot






Investor Presentation

Investor Presentation

View our latest Corporate Presentation

View Presentation